Treatment for attention-deficit hyperactivity disorder
US7504395B2 · kind B2 · utility
1Cited by
57References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 2002 |
| Grant date | Mar 17, 2009 |
| Priority date | — |
| Expiry date | Jul 19, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.